Cambridge Investment Research Advisors Inc. cut its stake in shares of Clorox Company (The) (NYSE:CLX) by 12.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 27,512 shares of the company’s stock after selling 3,922 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Clorox Company (The) were worth $3,629,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. American Beacon Advisors Inc. purchased a new stake in Clorox Company (The) during the 1st quarter valued at $104,000. Parkside Financial Bank & Trust raised its stake in Clorox Company (The) by 3.8% during the 2nd quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares during the last quarter. Valley National Advisers Inc. raised its stake in Clorox Company (The) by 0.6% during the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after buying an additional 5 shares during the last quarter. Sun Life Financial INC raised its stake in Clorox Company (The) by 10,344.4% during the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock valued at $125,000 after buying an additional 931 shares during the last quarter. Finally, Blue Chip Partners Inc. increased its stake in shares of Clorox Company (The) by 3.9% in the 2nd quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock worth $125,000 after purchasing an additional 35 shares in the last quarter. Institutional investors and hedge funds own 71.58% of the company’s stock.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the transaction, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP James E. Foster sold 9,861 shares of the stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the transaction, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. In the last ninety days, insiders sold 41,293 shares of company stock valued at $5,560,303. 1.00% of the stock is owned by insiders.

TRADEMARK VIOLATION NOTICE: This report was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/11/17/cambridge-investment-research-advisors-inc-decreases-holdings-in-clorox-company-the-clx.html.

Several equities research analysts have recently commented on CLX shares. BMO Capital Markets restated an “outperform” rating on shares of Clorox Company (The) in a research note on Tuesday, September 12th. Royal Bank Of Canada restated a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a research note on Sunday, October 8th. Deutsche Bank AG restated a “hold” rating and issued a $137.00 price objective (up from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Jefferies Group LLC restated a “hold” rating and issued a $132.00 price objective (down from $137.00) on shares of Clorox Company (The) in a research note on Friday, October 6th. Finally, Zacks Investment Research lowered Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $128.72.

Shares of Clorox Company (NYSE CLX) traded up $1.76 during trading hours on Friday, hitting $134.54. 690,100 shares of the company were exchanged, compared to its average volume of 815,937. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02. Clorox Company has a 1 year low of $112.28 and a 1 year high of $141.76. The company has a market cap of $17,350.00, a P/E ratio of 23.92, a price-to-earnings-growth ratio of 3.62 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating the Zacks’ consensus estimate of $1.41 by $0.05. Clorox Company (The) had a net margin of 11.84% and a return on equity of 161.59%. The firm had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter last year, the firm earned $1.36 EPS. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. equities research analysts predict that Clorox Company will post 5.58 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.50%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox Company (The)’s payout ratio is 61.65%.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.